生物制剂-话题@MedSci

#生物制剂#

122篇内容 | 3952人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1826017, encodeId=30d3182601e3e, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=JCC: 生物制剂和免疫调节剂联合疗法优于单一疗法，可减少与炎症性肠病相关并发症的风险, objectType=article, longId=201872, objectId=a9822018e210, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9822018e210, replyNumber=0, likeNumber=62, createdTime=2020-11-16, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9822018e210, moduleTitle=JCC: 生物制剂和免疫调节剂联合疗法优于单一疗法，可减少与炎症性肠病相关并发症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9822018e210)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826016, encodeId=c5f71826016d5, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=IBD:上皮细胞生物标记物可预测克罗恩病对生物制剂的反应, objectType=article, longId=201202, objectId=ad17201202da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad17201202da, replyNumber=0, likeNumber=75, createdTime=2021-07-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad17201202da, moduleTitle=IBD:上皮细胞生物标记物可预测克罗恩病对生物制剂的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad17201202da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826013, encodeId=73b5182601378, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发, objectType=article, longId=193976, objectId=40ab1939e692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ab1939e692, replyNumber=0, likeNumber=69, createdTime=2020-09-12, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ab1939e692, moduleTitle=FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ab1939e692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826008, encodeId=b98418260081d, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=J Rheumatol：生物制剂治疗银屑病关节炎的指炎和附着点炎, objectType=article, longId=186269, objectId=fc7518626908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc7518626908, replyNumber=0, likeNumber=59, createdTime=2020-07-01, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc7518626908, moduleTitle=J Rheumatol：生物制剂治疗银屑病关节炎的指炎和附着点炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc7518626908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826011, encodeId=18ed18260112f, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=FDA批准四价脑膜炎球菌疫苗MenQuadfi的生物制剂许可, objectType=article, longId=193026, objectId=8add1930261a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8add1930261a, replyNumber=0, likeNumber=65, createdTime=2020-09-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8add1930261a, moduleTitle=FDA批准四价脑膜炎球菌疫苗MenQuadfi的生物制剂许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8add1930261a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826009, encodeId=f39f1826009ab, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=DCR：生物制剂对克罗恩病手术患者术后30天内的并发症的影响, objectType=article, longId=186979, objectId=a0ee1869e92e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0ee1869e92e, replyNumber=0, likeNumber=60, createdTime=2020-06-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0ee1869e92e, moduleTitle=DCR：生物制剂对克罗恩病手术患者术后30天内的并发症的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0ee1869e92e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826007, encodeId=6b76182600eb1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=新一代白介素生物制剂破译“银屑病”密码首公开, objectType=article, longId=186216, objectId=7f8f18621686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f8f18621686, replyNumber=0, likeNumber=58, createdTime=2020-10-03, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f8f18621686, moduleTitle=新一代白介素生物制剂破译“银屑病”密码首公开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f8f18621686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826005, encodeId=c2ad1826005c9, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：银屑病或银屑病关节炎使用生物制剂出现严重感染的相对风险, objectType=article, longId=183184, objectId=9ce4183184a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce4183184a8, replyNumber=0, likeNumber=79, createdTime=2020-08-26, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce4183184a8, moduleTitle=Ann Rheum Dis：银屑病或银屑病关节炎使用生物制剂出现严重感染的相对风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce4183184a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826004, encodeId=0a3618260043a, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Clin Gastroenterology H：炎症性肠病患者使用生物制剂仿制药的效果分析, objectType=article, longId=183174, objectId=8e611831e42e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e611831e42e, replyNumber=0, likeNumber=58, createdTime=2020-01-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e611831e42e, moduleTitle=Clin Gastroenterology H：炎症性肠病患者使用生物制剂仿制药的效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e611831e42e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826001, encodeId=62b71826001f1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Clin Gastroenterology H：生物制剂联合免疫抑制剂治疗炎症性肠病患者可以降低相关并发症的风险, objectType=article, longId=176790, objectId=df3a1e6790b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df3a1e6790b3, replyNumber=0, likeNumber=57, createdTime=2019-09-17, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df3a1e6790b3, moduleTitle=Clin Gastroenterology H：生物制剂联合免疫抑制剂治疗炎症性肠病患者可以降低相关并发症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df3a1e6790b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826006, encodeId=c3d3182600661, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Ann Rheum Dis：风湿病生物制剂使用者中的结核, objectType=article, longId=184170, objectId=a1251841e0ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1251841e0ec, replyNumber=0, likeNumber=53, createdTime=2020-04-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1251841e0ec, moduleTitle=Ann Rheum Dis：风湿病生物制剂使用者中的结核, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1251841e0ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826002, encodeId=6e97182600285, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, objectType=article, longId=182540, objectId=b84d182540dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b84d182540dd, replyNumber=0, likeNumber=69, createdTime=2020-05-04, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b84d182540dd, moduleTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b84d182540dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826003, encodeId=e1eb182600301, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, objectType=article, longId=182567, objectId=ec7418256ef8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec7418256ef8, replyNumber=0, likeNumber=58, createdTime=2020-05-25, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec7418256ef8, moduleTitle=全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec7418256ef8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1826000, encodeId=e961182600092, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市, objectType=article, longId=167787, objectId=f96e16e787c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96e16e787c7, replyNumber=0, likeNumber=93, createdTime=2020-01-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96e16e787c7, moduleTitle=西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f96e16e787c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825993, encodeId=b55e182599382, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=西安杨森旗下类克为中国溃疡性结肠炎提供生物制剂新选择, objectType=article, longId=160429, objectId=fcac16042929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcac16042929, replyNumber=0, likeNumber=95, createdTime=2019-02-25, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcac16042929, moduleTitle=西安杨森旗下类克为中国溃疡性结肠炎提供生物制剂新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcac16042929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825995, encodeId=70f11825995d3, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2019 CDA实践指南：生物制剂治疗银屑病, objectType=article, longId=161738, objectId=5761161e38b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5761161e38b7, replyNumber=0, likeNumber=29, createdTime=2019-08-10, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5761161e38b7, moduleTitle=2019 CDA实践指南：生物制剂治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5761161e38b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825999, encodeId=e3bd1825999da, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Dig Liver Dis：生物制剂使用时小肠克罗恩病狭窄成形术后早期复发的影响因素, objectType=article, longId=166563, objectId=18811665633f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18811665633f, replyNumber=0, likeNumber=62, createdTime=2019-09-30, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18811665633f, moduleTitle=Dig Liver Dis：生物制剂使用时小肠克罗恩病狭窄成形术后早期复发的影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18811665633f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825994, encodeId=6bb91825994f1, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=2019 AAD/NPF指南：应用生物制剂治疗银屑病, objectType=article, longId=161044, objectId=e8ab16104440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8ab16104440, replyNumber=0, likeNumber=28, createdTime=2019-08-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8ab16104440, moduleTitle=2019 AAD/NPF指南：应用生物制剂治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8ab16104440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825998, encodeId=ebc31825998e8, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性, objectType=article, longId=164931, objectId=89191649313a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89191649313a, replyNumber=0, likeNumber=59, createdTime=2019-07-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89191649313a, moduleTitle=Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89191649313a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1825991, encodeId=9aab182599116, content=<a href='/topic/show?id=6191692233a' target=_blank style='color:#2F92EE;'>#生物制剂#</a>, objectTitle=三个原则，帮你判断该不该用生物制剂, objectType=article, longId=152460, objectId=3b9615246089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b9615246089, replyNumber=0, likeNumber=56, createdTime=2018-11-05, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b9615246089, moduleTitle=三个原则，帮你判断该不该用生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b9615246089)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物制剂

2020-05-29发表于威斯康星

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

JCC: 生物制剂和免疫调节剂联合疗法优于单一疗法，可减少与炎症性肠病相关并发症的风险

2020-11-16

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

IBD:上皮细胞生物标记物可预测克罗恩病对生物制剂的反应

2021-07-13

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

FDA指南简介：拓展队列用于首次人体试验加速抗肿瘤药物/生物制剂的开发

2020-09-12

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

J Rheumatol：生物制剂治疗银屑病关节炎的指炎和附着点炎

2020-07-01

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

FDA批准四价脑膜炎球菌疫苗MenQuadfi的生物制剂许可

2020-09-27

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

DCR：生物制剂对克罗恩病手术患者术后30天内的并发症的影响

2020-06-07

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

新一代白介素生物制剂破译“银屑病”密码首公开

2020-10-03

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：银屑病或银屑病关节炎使用生物制剂出现严重感染的相对风险

2020-08-26

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

Clin Gastroenterology H：炎症性肠病患者使用生物制剂仿制药的效果分析

2020-01-29

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

Clin Gastroenterology H：生物制剂联合免疫抑制剂治疗炎症性肠病患者可以降低相关并发症的风险

2019-09-17

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

Ann Rheum Dis：风湿病生物制剂使用者中的结核

2020-04-29

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会

2020-05-04

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

全球特应性皮炎靶向生物制剂Dupixent® 亮相进博会

2020-05-25

一叶知秋 (审核中...)

前往app查看评论内容

#生物制剂#

西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市

2020-01-23

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

西安杨森旗下类克为中国溃疡性结肠炎提供生物制剂新选择

2019-02-25

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2019 CDA实践指南：生物制剂治疗银屑病

2019-08-10

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Dig Liver Dis：生物制剂使用时小肠克罗恩病狭窄成形术后早期复发的影响因素

2019-09-30

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

2019 AAD/NPF指南：应用生物制剂治疗银屑病

2019-08-21

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

Semin Arthritis Rheu：老年类风湿性关节炎患者使用生物制剂的疗效和安全性

2019-07-28

bluefate121 (审核中...)

前往app查看评论内容

#生物制剂#

三个原则，帮你判断该不该用生物制剂

2018-11-05

科室
- - 订阅+
  - 更多科室
工具
服务